Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Development of a rat model of sexual performance anxiety: effect of behavioural and pharmacological hyperadrenergic stimulation on APO-induced erections

International Journal of Impotence Research volume 14, pages 107–115 (2002)Cite this article

Abstract

As part of the multifactorial nature of erectile dysfunction, anxiety associated with sexual performance (SPA) remains a major contributing factor to its progression. In fact, the heightened sympathetic activity associated with sexual performance anxiety may be a key early component of this disruption of normal erectile responses. We are not aware that any animal models have been developed to assess this phenomenon. Using apomorphine (APO, 80 μg/kg s.c.)-induced erections in rats we characterised the effects of behavioural or pharmacological hyperadrenergic stimulation (that is, anxiety) on erections and hemodynamics. We developed an experimental SPA paradigm by exposing male rats to the stress of being observed by a larger, older male rat placed in close proximity to test rats during APO testing. In a separate group, adrenergic stress was simulated using a sympathomimetic, methoxamine (MXA) given prior to APO testing. In a third group, the changes in circulatory parameters (mean arterial pressure, heart rate) were determined following instrumentation with radiotelemetric transducers for each scenario. APO-induced erections were significantly lower in both the behavioural (1.25±0.8) and pharmacological (0.33±0.5) stressor paradigms compared to controls (2.81±0.9). Further, erections in MXA-treated rats were significantly lower than in the observed scenario. Despite the differences in erections hemodynamic assessments showed no differences in MAP or HR changes between the different experimental conditions. Thus, both the behavioural and pharmacological paradigms of SPA decreased erections, but did not affect the circulation. This suggests that the level of hyperadrenergic input required to induce erectile dysfunction can be subtle, and target only erectogenic pathways.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Masters WH, Johnson VE. . Human Sexual Inadequacy Little Brown: Boston 1970

  2. Heaton JPW, Adams MA, Morales A. . A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperative. Int J Impot Res 1997 9: 115–121.

    Article  CAS  Google Scholar 

  3. Feldman HA et al . Impotence and its medial and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994 151: 54.

    Article  Google Scholar 

  4. Penson DF et al . Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biol Reprod 1996 55: 567–574.

    Article  CAS  Google Scholar 

  5. Benson GS. . Endocrine factors related to impotence. In: Bennett AH (ed). Impotence Saunders: Philadelphia 1994 31–41.

    Google Scholar 

  6. Adams MA et al . Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems. Int J Impot Res 1997 9: 1–7.

    Article  Google Scholar 

  7. Segraves KB, Segraves RT. . Psychogenic impotence. In: Bennett AH (ed). Impotence Saunders: Philadelphia 1994 92–105.

    Google Scholar 

  8. Norton GR, Jehu D. . The role of anxiety in sexual dysfunctions: a review. Arch Sex Behav 1984 13: 164–183.

    Article  Google Scholar 

  9. Holmes DS. . Abnormal Psychology, 2nd edn. Harper Collins Publishers: New York 1994

  10. Eysenck MW, MacLeod C, Mathews A. . Cognitive functioning and anxiety. Psychol Res 1987 49: 189–195.

    Article  CAS  Google Scholar 

  11. Hale VE, Strassberg DS. . The role of anxiety on sexual arousal. Arch Sex Behav 1990 19: 569–581.

    Article  CAS  Google Scholar 

  12. Heaton JPW, Varrin SJ, Morales A. . The characterization of a bio-assay of erectile function in a rat model. J Urol 1991 145: 1099–1102.

    Article  CAS  Google Scholar 

  13. Melis MR, Mauri A, Argiolas A. . Apomorphine- and oxytocin-induced penile erection and yawning in intact and castrated male rats: effect of sexual steroids. Neuroendocronology 1994 59: 349–354.

    Article  CAS  Google Scholar 

  14. Melis MR, Argiolas A, Gessa GL. . Apomorphine-induced penile erection and yawning: site of action in brain. Brain Res 1987 415: 98–104.

    Article  CAS  Google Scholar 

  15. Paick JS, Lee SW. . The neural mechanism of apomorphine-induced erection: and experimental study by comparison with electrostimulation-induced erection in the rat model. J Urol 1994 152: 2125–2128.

    Article  CAS  Google Scholar 

  16. Taylor GT, Weiss J, Rupich R. . Male rat behaviour, endocrinology and reproductive physiology in a mixed-sex, socially stressful colony. Physiol Behav 1987 39: 429–433.

    Article  CAS  Google Scholar 

  17. D'Amato FR, Pavone F. . Role of anxiety in subordinate male mice sexual behaviour. Pharmacol Biochem Behav 1992 43: 181–185.

    Article  CAS  Google Scholar 

  18. Berntson GG, Cacioppo JT, Quigley KS. . Cardiac psychophysiology and autonomic space in humans: empirical perspectives and conceptual implications. Psych Bull 1993 114: 296–322.

    Article  CAS  Google Scholar 

  19. Mabry TR, Gold PE, McCarty R. . Age-related changes in plasma catecholamine responses to acute swim stress. Neurobiol Learning Memory 1995 63: 260–268.

    Article  CAS  Google Scholar 

  20. Weinstock M et al . Gender differences in sympathoadrenal activity in rats at rest and in response to footshock stress. Int J Develop Neurosci 1998 16: 289–295.

    Article  CAS  Google Scholar 

  21. Nankova BB, Sabban EL. . Multiple signalling pathways exist in the stress-triggered regulation of gene expression for cate-cholamine biosynthetic enzymes and several neuropeptides in the rat adrenal medulla. Acta Physiol Scand 1999 167: 1–9.

    Article  CAS  Google Scholar 

  22. Caggiula AR, Shaw DH, Antelman M, Edwards DJ. . Interactive effects of brain catecholamines and variations in sexual and non-sexual arousal on copulatory behavior of male rats. Brain Res 1976 111: 321–336.

    Article  CAS  Google Scholar 

  23. Ushijima I et al . Effects of age on behavioral responses to dopamine agonists in the rat. Eur J Pharmacol 1987 138: 101–106.

    Article  CAS  Google Scholar 

  24. Adams MA, Banting JD, Manabe K, Heaton JPW. . Common features regulating the systemic circulation and the penile vasculature. In: Morales A (ed). Erectile Dysfunction: Current Issues in Pharmacotherapy. Martin Dunitz Ltd: London 1998 27–38.

    Google Scholar 

  25. Reboucas RC, Schmidek WR. . Handling and isolation in three strains of rats affect open field, exploration, hoarding and predation. Physiol Behav 1997 62: 1159–1164.

    Article  CAS  Google Scholar 

  26. Adams MA et al . Prolonged high dose L-NAME does not abolish apomorphine-induced erections in rats. Int J Impot Res 1994 6: Suppl 1 A4.

    Google Scholar 

  27. Whittingham HA et al . Erectile dysfunction induced by acute NO synthase blockade is reversed by an endothelin receptor antagonist. Int J Impot Res 1996 8: Suppl 3 100 (A06).

    Google Scholar 

  28. Gofton WT et al . Characteristics of the specificity of vasoconstrictor and vasodilator systems in diminishing erectile function in vivo Int J Impot Res 1995 7: Suppl 1 37(D1).

    Google Scholar 

  29. Lue TF. . Physiology of erection and pathophysiology of impotence. In: Walsh PC, Retik TA, Stamey ED, Vaugn WB (eds). Campbell's Urology, 6th Edition. Saunders Company: Philadelphia 1992 702–722.

    Google Scholar 

  30. Andersson, K. . Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 1993 45: 253–308.

    Google Scholar 

  31. Christ GJ, Maayani S, Valcic M, Melman A. . Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in α-adrenoceptor responsiveness with age and disease in isolated tissues. Br J Pharmacol 1990 101: 375–381.

    Article  CAS  Google Scholar 

  32. Rossi P et al . Comparison between plasma concentrations of testosterone, nitric oxide and endothelin 1–2 in penile and brachial venous blood: preliminary results in men with psychogenic impotence. Biomed Pharmacother 1998 52: 308–310.

    Article  CAS  Google Scholar 

  33. Dittrich A, Albrecht K, Bar-Moshe O, Vandendris M. . Treatment of pharmacological priapism with phenylephrine. J Urol 1991 146: 323–324.

    Article  CAS  Google Scholar 

  34. Levine FJ, Saenz de Tajada I, Payton TR, Goldstein I. . Recurrent prolonged erections and priapism as a sequela of priapism: pathophysiology and management. J Urol 1991 145: 764–767.

    Article  CAS  Google Scholar 

  35. Alexander W. . Detumescence by exercise bicycle. Lancet 1989 1: 735.

    Article  Google Scholar 

  36. Guiliano F, Bernabe J, Jardin A, Rousseau JP. . Antierectile role of the sympathetic nervous system in rats. J Urol 1993 150: 519–524.

    Article  Google Scholar 

  37. Hoffman BB, Lefkowitz RJ. . Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds). The Pharmacological Basis of Therapeutics, 9th Edition. McGraw-Hill Companies: New York 1996 199–248.

    Google Scholar 

Download references

Acknowledgements

The authors thank Shannon Parker for her technical support. The Kidney Foundation of Canada, and the Heart and Stroke Foundation of Ontario provided research funding for this investigation. SEB is a recipient of a Canadian Institutes of Health Research Doctoral Award.

Author information

Authors and Affiliations

  1. Departments of Pharmacology and Toxicology, Kingston, Ontario, Canada

    S E Brien, C Smallegange, W T Gofton, J P W Heaton & M A Adams

  2. Department of Urology, Queen's University, Kingston, Ontario, Canada

    J P W Heaton & M A Adams

  3. The Human Sexuality Group, Kingston General Hospital, Kingston, Ontario, Canada

    J P W Heaton

Authors
  1. S E Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Smallegange
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W T Gofton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J P W Heaton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M A Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M A Adams.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brien, S., Smallegange, C., Gofton, W. et al. Development of a rat model of sexual performance anxiety: effect of behavioural and pharmacological hyperadrenergic stimulation on APO-induced erections. Int J Impot Res 14, 107–115 (2002). https://doi.org/10.1038/sj.ijir.3900836

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900836

Keywords

This article is cited by

Search

Advanced search

Quick links